177LuPSMA in Renal Cell Carcinoma

Clinical trial NCT06964958 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06964958
Sponsor: Dana-Farber Cancer Institute
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma Advanced Clear Cell Renal Cell Carcinoma Kidney Cancer

Start date: 2025-07-31
Primary completion: 2026-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.